个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
周二盘中交易时段,12只医疗保健类股走势
Gainers
- Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 150.2% to $2.0 during Tuesday's regular session. Trading volume for Celyad Oncology's stock is 50.4 million as of 12:30 EST. This is 563061.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.1 million.
- Calyxt (NASDAQ:CLXT) shares increased by 109.47% to $0.39. The current volume of 66.6 million shares is 16560.9% of Calyxt's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $18.9 million.
- Theseus Pharmaceuticals (NASDAQ:THRX) stock moved upwards by 27.4% to $12.23. As of 12:30 EST, this security is trading at a volume of 604.1K shares, making up 377.1% of its average full-day volume over the last 100 days. The company's market cap stands at $473.5 million.
- Avenue Therapeutics (NASDAQ:ATXI) stock increased by 27.05% to $1.55. As of 12:30 EST, Avenue Therapeutics's stock is trading at a volume of 3.2 million, which is 169.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.4 million.
- OKYO Pharma (NASDAQ:OKYO) shares increased by 25.87% to $2.5. The market value of their outstanding shares is at $54.5 million.
- Fortress Biotech (NASDAQ:FBIO) shares increased by 23.61% to $1.09. Fortress Biotech's stock is trading at a volume of 786.1K shares as of 12:30 EST. This is 230.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.3 million.
Losers
- Viveve Medical (NASDAQ:VIVE) stock declined by 69.9% to $0.26 during Tuesday's regular session. Viveve Medical's stock is trading at a volume of 5.4 million shares as of 12:30 EST. This is 6444.3% of its average full-day volume over the last 100 days. The company's market cap stands at $2.7 million.
- Leap Therapeutics (NASDAQ:LPTX) shares decreased by 16.75% to $0.49. As of 12:30 EST, this security is trading at a volume of 2.6 million shares, making up 438.3% of its average full-day volume over the last 100 days. The company's market cap stands at $48.0 million.
- Acer Therapeutics (NASDAQ:ACER) shares decreased by 16.51% to $2.5. The current volume of 860.6K shares is 159.3% of Acer Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $49.3 million.
- Rain Oncology (NASDAQ:RAIN) shares fell 16.36% to $9.0. As of 12:30 EST, this security is trading at a volume of 273.3K shares, making up 256.6% of its average full-day volume over the last 100 days. The company's market cap stands at $316.2 million.
- Rubius Therapeutics (NASDAQ:RUBY) shares decreased by 14.15% to $0.25. The current volume of 973.3K shares is 81.8% of Rubius Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $22.8 million.
- Ontrak (NASDAQ:OTRKP) stock fell 13.82% to $0.81. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 150.2% to $2.0 during Tuesday's regular session. Trading volume for Celyad Oncology's stock is 50.4 million as of 12:30 EST. This is 563061.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.1 million.
- Calyxt (NASDAQ:CLXT) shares increased by 109.47% to $0.39. The current volume of 66.6 million shares is 16560.9% of Calyxt's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $18.9 million.
- Theseus Pharmaceuticals (NASDAQ:THRX) stock moved upwards by 27.4% to $12.23. As of 12:30 EST, this security is trading at a volume of 604.1K shares, making up 377.1% of its average full-day volume over the last 100 days. The company's market cap stands at $473.5 million.
- Avenue Therapeutics (NASDAQ:ATXI) stock increased by 27.05% to $1.55. As of 12:30 EST, Avenue Therapeutics's stock is trading at a volume of 3.2 million, which is 169.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.4 million.
- OKYO Pharma (NASDAQ:OKYO) shares increased by 25.87% to $2.5. The market value of their outstanding shares is at $54.5 million.
- Fortress Biotech (NASDAQ:FBIO) shares increased by 23.61% to $1.09. Fortress Biotech's stock is trading at a volume of 786.1K shares as of 12:30 EST. This is 230.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.3 million.
- Celyad 肿瘤学 纳斯达克股票代码:CYAD)股价在周二的例行交易中上涨了150.2%,至2.0美元。截至美国东部标准时间 12:30,Celyad Oncology股票的交易量为5,040万股。这是其过去100天平均全日交易量的563061.1%。他们已发行股票的市值为4510万美元。
- Calyxt 纳斯达克股票代码:CLXT)的股价上涨了109.47%,至0.39美元。目前的6,660万股成交量是Calyxt过去100天(上次更新时间为美国东部标准时间 12:30)平均全日成交量的16560.9%。该公司的市值为1,890万美元。
- 修斯制药 纳斯达克股票代码:THRX)的股票上涨了27.4%,至12.23美元。截至美国东部标准时间 12:30,该证券的交易量为604.1万股,占其过去100天平均全日交易量的377.1%。该公司的市值为4.735亿美元。
- Avenuetics 纳斯达克股票代码:ATXI)的股票上涨了27.05%,至1.55美元。截至美国东部标准时间 12:30,Avenue Therapeutics的股票交易量为320万股,占其过去100天平均全日交易量的169.3%。他们已发行股票的市值为740万美元。
- OKYO 制药 纳斯达克股票代码:OKYO)的股价上涨了25.87%,至2.5美元。他们已发行股票的市值为5,450万美元。
- 丰泽生物科技 纳斯达克股票代码:FBIO)的股价上涨了23.61%,至1.09美元。截至美国东部标准时间 12:30,Fortress Biotech的股票交易量为786.1万股。这是其过去 100 天平均全日交易量的230.3%。他们已发行股票的市值为1.183亿美元。
Losers
失败者
- Viveve Medical (NASDAQ:VIVE) stock declined by 69.9% to $0.26 during Tuesday's regular session. Viveve Medical's stock is trading at a volume of 5.4 million shares as of 12:30 EST. This is 6444.3% of its average full-day volume over the last 100 days. The company's market cap stands at $2.7 million.
- Leap Therapeutics (NASDAQ:LPTX) shares decreased by 16.75% to $0.49. As of 12:30 EST, this security is trading at a volume of 2.6 million shares, making up 438.3% of its average full-day volume over the last 100 days. The company's market cap stands at $48.0 million.
- Acer Therapeutics (NASDAQ:ACER) shares decreased by 16.51% to $2.5. The current volume of 860.6K shares is 159.3% of Acer Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $49.3 million.
- Rain Oncology (NASDAQ:RAIN) shares fell 16.36% to $9.0. As of 12:30 EST, this security is trading at a volume of 273.3K shares, making up 256.6% of its average full-day volume over the last 100 days. The company's market cap stands at $316.2 million.
- Rubius Therapeutics (NASDAQ:RUBY) shares decreased by 14.15% to $0.25. The current volume of 973.3K shares is 81.8% of Rubius Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $22.8 million.
- Ontrak (NASDAQ:OTRKP) stock fell 13.82% to $0.81. See Also:
- Viveve 医疗 纳斯达克股票代码:VIVE)股价在周二的例行交易中下跌了69.9%,至0.26美元。截至美国东部标准时间 12:30,Viveve Medical的股票交易量为540万股。这是其过去 100 天平均全日交易量的6444.3%。该公司的市值为270万美元。
- Leap 疗法 纳斯达克股票代码:LPTX)股价下跌16.75%,至0.49美元。截至美国东部标准时间 12:30,该证券的交易量为260万股,占其过去100天平均全日交易量的438.3%。该公司的市值为4,800万美元。
- 宏碁疗法 纳斯达克股票代码:ACER)股价下跌16.51%,至2.5美元。目前的860.6K股成交量是宏碁Therapeutics过去100天(上次更新时间为美国东部标准时间 12:30)平均全日成交量的159.3%。他们已发行股票的市值为4,930万美元。
- 雨水肿瘤学 纳斯达克股票代码:RAIN)股价下跌16.36%,至9.0美元。截至美国东部标准时间 12:30,该证券的交易量为273.3万股,占其过去100天平均全日交易量的256.6%。该公司的市值为3.162亿美元。
- 鲁比乌斯疗法 纳斯达克股票代码:RUBY)股价下跌14.15%,至0.25美元。目前973.3K股的成交量是Rubius Therapeutics过去100天(上次更新时间为美国东部标准时间 12:30)平均全日交易量的81.8%。该公司的市值为2280万美元。
- Ontrak 纳斯达克股票代码:OTRKP)股价下跌13.82%,至0.81美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!